About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | ALS Clinical Trials | 10 Studies Recruiting

Clinical TrialsALS

ALS Clinical Trials

Browse 10 clinical trials for als. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-10 of 10 trials

No longer availableExpanded Access Protocol of BHV-0223 for Patients With Amyotrophic Lateral Sclerosis (ALS)This is an open label expanded access protocol for the treatment of up to approximately 250 adult patients with amyotrophic lateral sclerosis (ALS) who have difficulty swallowing…NCT03537807 UnknownMRG-001 in Patients With Amyotrophic Lateral SclerosisThe proposed study is an Open-Label, Single-Dose Study to Assess the Safety, and Pharmacodynamics (PD) signals of MRG-001 in Patients with Amyotrophic Lateral Sclerosis (ALS).NCT06315608 UnknownFar Infrared Irradiation for Control, Management and Treatment of Amyotrophic Lateral Sclerosis (ALS)Amyotrophic Lateral Sclerosis (ALS, sometimes called Lou Gehrig's s Disease, or Maladie de Charcot) is a progressive, usually fatal, neurodegenerative disease caused by the…NCT00673140·Toronto, Ontario CompletedClinical Trial of Ezogabine (Retigabine) in ALS SubjectsThis study evaluates the effect of retigabine (600 mg/day, 900 mg/day, or placebo) on motor neuron activity in people with Amyotrophic Lateral Sclerosis (ALS).NCT02450552·Phoenix, Arizona and 11 others

Related Searches

amyotrophic lateral sclerosistrials lou gehrigtrials

Data from ClinicalTrials.govTerms

CompletedSpeech Analysis in ALS PatientsThe purpose of this study is to find out if changes in speech can signal changes in the ability to think or remember.NCT03868345·Phoenix, Arizona

CompletedOpen-label Study to Evaluate Safety, Tolerability and PK of BHV-0223 in ALSPhase 1, open-label study of BHV-0223 in ALS.NCT03520517·Fort Lauderdale, Florida and 4 others

CompletedOpen-Label, Safety and Tolerability Extension Study of KNS-760704 in Amyotrophic Lateral Sclerosis (ALS) (CL211)This is an open-label, multi-center study designed to extend the evaluation of the safety, tolerability, and clinical effects of oral administration of KNS-760704 in patients with…NCT00931944·Little Rock, Arkansas and 18 others

UnknownRehabilitation in SOD1 ALS Treated With TofersenThe primary objective of this study is to document and describe the effects of a personalized rehabilitation program for patients with SOD1 ALS participating in the tofersen…NCT05725759·St Louis, Missouri

CompletedSafety and Tolerability Study of KNS-760704 in Amyotrophic Lateral Sclerosis (ALS)This was a 2-part study of dexpramipexole in patients with ALS.NCT00647296·Little Rock, Arkansas and 20 others

RecruitingSafety and Tolerability Study of CTx1000 In Participants With Amyotrophic Lateral SclerosisThis clinical study is in participants with Amyotrophic Lateral Sclerosis and is designed to evaluate the safety and tolerability of the gene therapy CTx1000.NCT07401121·Sydney, New South Wales